Burzynski Research Institute, Inc. (BZYR)
OTCMKTS · Delayed Price · Currency is USD
0.0020
0.00 (0.00%)
Sep 4, 2026, 4:00 PM EST
BZYR Market Cap
BZYR has a market cap or net worth of $262.9 thousand as of September 8, 2026. Its market cap has decreased by -92.31% in one year.
Market Cap
262.90K
Enterprise Value
260.73K
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
ChartMarket Cap Chart
Since April 28, 1997, BZYR's market cap has decreased from 16.41M to 262.90K, a decrease of -98.40%. That is a compound annual growth rate of -13.13%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2026 | 262.90K | -89.53% |
| Dec 29, 2025 | 2.51M | -38.39% |
| Dec 31, 2024 | 4.07M | -29.55% |
| Dec 29, 2023 | 5.78M | 70.28% |
| Dec 23, 2022 | 3.40M | 115.33% |
| Dec 31, 2021 | 1.58M | -33.33% |
| Dec 16, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Altamira Therapeutics | 405.80K |
| Actavia Life Sciences | 385.91K |
| Lyra Therapeutics | 354.98K |
| Sorrento Therapeutics | 326.23K |
| Orgenesis | 320.45K |
| MetaStat | 319.73K |
| Zenith Capital | 319.46K |
| NKGen Biotech | 261.20K |